A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
Clinical trial NCT03343067 · TERMINATED
Trial details
- NCT number
- NCT03343067
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2018-10-23
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.